Skip to main content
OpenTrials

Clinical trial condition

Virus Diseases

Explore clinical trials studying Virus Diseases. Study availability and eligibility vary by location and protocol.

19,075 public trials 1,287 recruiting studies
Refine in advanced search Browse all conditions

Virus Diseases trial results

Recruiting

AGILE (Early Phase Platform Trial for COVID-19)

NCT04746183

Conditions
COVID-19, Coronaviridae Infections, Coronavirus Infections, +10 more
Locations
  • Desmond Tutu Health Foundation Cape Town, South Africa
  • Ezintsha Johannesburg, South Africa
  • Liverpool University Hospitals NHS Foundation Trust Liverpool, United Kingdom
  • Kings College Hospital NHS Foundation Trust London, United Kingdom
View Trial Details
Recruiting

Collecting Blood and Tissue Sample Donations for Research for HIV/AIDS-Related Cancers

NCT05663502

Conditions
Anal Carcinoma, Anus Diseases, Anus Neoplasms, +53 more
Locations
  • UC San Diego Moores Cancer Center La Jolla, California, United States
  • University of California, San Francisco San Francisco, California, United States
  • George Washington University Washington D.C., District of Columbia, United States
  • University of Miami Miami, Florida, United States
View Trial Details
Recruiting

Letermovir Prophylaxis Duration Guided by CMV-Specific T-cell Monitoring After Allo-HSCT.

NCT07569653

Conditions
Cytomegalovirus Disease, Cytomegalovirus Infections, DNA Virus Infections, +6 more
Locations
  • Chinese PLA General Hospital Beijing, Beijing Municipality, China
  • The Second Hospital of Hebei Medical University Shijiazhuang, Hebei, China
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details
Recruiting

A Study on the Immune Response and Safety of an Investigational Chickenpox Vaccine and a Marketed Measles, Mumps and Rubella Vaccine When Administered as Intramuscular Injection to Healthy Children 12 to 15 Months of Age

NCT06855160

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Tucson, Arizona, United States
  • GSK Investigational Site Huntington Park, California, United States
  • GSK Investigational Site Sherman Oaks, California, United States
  • GSK Investigational Site Coral Gables, Florida, United States
View all 22 locations
View Trial Details
Recruiting

A Study on the Immune Response and Safety of the Second Dose of an Investigational Chickenpox Vaccine When Given to Healthy Children 3 Months After a First Dose at 12 to 15 Months of Age

NCT06806137

Conditions
Chickenpox, DNA Virus Infections, Herpesviridae Infections, +3 more
Locations
  • GSK Investigational Site Salvaleón de Higüey, La Altagracia Province, Dominican Republic
  • GSK Investigational Site Constanza, Dominican Republic
  • GSK Investigational Site Santo Domingo Oeste, Dominican Republic
  • GSK Investigational Site San Pedro Sula, Honduras
View Trial Details

Related conditions